Primary outcomes | Definition |
---|---|
Retention | Alive and in care at each 12-month time point following enrollment |
Viral suppression | The proportion of individuals alive and in care whose viral load is below 1000 copies/mL (virally suppressed) after six months on treatment |
Secondary outcomes | Definition |
Retention | At each six-month time point following enrollment |
Viral suppression | At each six-month time point following enrollment |
Mortality | At each six-month time point following enrollment |
Visit adherence among those initiated on ART | Proportion of missed visits as a number of scheduled appointments among ART-ineligible patients by end of follow-up |
Drug resistance | Proportion of drug resistance among ART-ineligible patients with two virological failures who have received genotype resistance testing |
Tuberculosis | Proportion of ART-ineligible patients diagnosed with tuberculosis following enrolment (recurrent and new incident) |
ART uptake among those who are eligible | Proportion of HIV-positive individuals who are eligible for initiation who are successfully initiated to ART within on the day of, within two weeks, and one and three months of becoming eligible |
Cost per patient per year | Average public and private healthcare expenditures per patient |
Patient satisfaction | Average patient satisfaction |
Provider satisfaction | Average job satisfaction among the professionals providing HIV treatment |
Patients’ employment, income, and education | Average patients’ employment, income, and educational attainment |